News about Manufacturing

AstraZeneca to Build Cell Therapy Hub and Innovation Centre in Shanghai

AstraZeneca has announced plans to set up a new cell therapy manufacturing and supply base along with an innovation centre in Shanghai, strengthening its presence in one of its key global markets.

Manufacturing | 20/03/2026 | By Darshana |  179

LGM Pharma Expands US Manufacturing, Invests USD 15 Million in Texas and Colorado

LGM Pharma has expanded its US manufacturing with a total USD 15 million investment across Texas and Colorado, boosting CDMO capacity for suppository, semi-solid and oral solid dose production while strengthening domestic supply chains for finished dosage manufacturing.

Manufacturing | 20/03/2026 | By News Bureau |  153

Lupin Manufacturing Solutions Scales Up Dabhasa Manufacturing Facility

Lupin Manufacturing Solutions has expanded its Dabhasa facility with a new block and dedicated peptide manufacturing units, strengthening its CRDMO capabilities and boosting capacity for advanced pharma development and production.

Manufacturing | 19/03/2026 | By News Bureau |  151

Dr Jitendra Singh Lays Foundation for INR 600 Crore Orchid Pharma Project in J&K

Dr Jitendra Singh laid the foundation for an INR 600 crore multinational pharma manufacturing facility in Kathua, highlighting the region’s rising industrial potential and its role in strengthening India’s pharma exports and economic growth.

Manufacturing | 18/03/2026 | By Akanki |  180

Eli Lilly Commits USD 3 Billion To Expand China Manufacturing

Eli Lilly and Company plans to invest USD 3 billion in China over the next decade to expand its local manufacturing and supply chain capabilities as it prepares for potential demand for new diabetes and obesity treatments.

Manufacturing | 12/03/2026 | By Darshana |  156

VolitionRx Completes Automation Validation For Nu.Q Vet Cancer Test In Japan

VolitionRx Limited has completed validation and verification of the chemiluminescent immunoassay (ChLIA) version of its Nu.Q Vet Cancer Test in collaboration with Fujifilm Vet Systems Co. Ltd in Japan, enabling the test to be run through fully automated systems in central laboratories instead of manual plates.

Manufacturing | 09/03/2026 | By Darshana |  165

U.S. Food and Drug Administration Grants De Novo Classification to LifeVac as Second-Line Emergency Treatment

U.S. Food and Drug Administration grants De Novo clearance to LifeVac, classifying it as a Class II medical device for use as a second-line treatment in choking emergencies.

Manufacturing | 09/03/2026 | By News Bureau |  435

Cipla USA Recalls Cancer Drug Batches Over Manufacturing Issue

The recall involves Nilotinib capsules in two strengths—150 mg and 200 mg—distributed in the US market. The affected batches include a total of 435 cartons, comprising 271 cartons from one lot and 164 from another.

Manufacturing | 09/03/2026 | By Darshana |  211

Servier Strikes USD 2.5 Billion Deal to Buy Day One Biopharmaceuticals

French drugmaker Servier has agreed to acquire US-based Day One Biopharmaceuticals in an all-cash deal valued at approximately USD 2.5 billion, as the company seeks to strengthen its presence in rare oncology and brain tumour therapies.

Manufacturing | 07/03/2026 | By Darshana |  156

Ultrasound AI Secures FDA De Novo Clearance for Delivery Date AI Technology

FDA grants De Novo clearance to cloud-based Delivery Date AI, enabling real-time predicted delivery dates from standard ultrasound images to support clinical decisions in pregnancies with uncertain dating.

Manufacturing | 03/03/2026 | By News Bureau |  602